Literature DB >> 19256306

Toll-like receptors in skin.

Lloyd S Miller1.   

Abstract

TLRs have emerged as a major class of PRRs that are involved in detecting invading pathogens in the skin and initiating cutaneous immune responses. TLRs are expressed on many different cell types in the skin, including keratinocytes and Langerhans cells in the epidermis. Each TLR can recognize a different microbial component and there are differences among the TLR signaling pathways, which lead to distinct immune responses against a given pathogen. Certain TLRs have been implicated in the pathogenesis of skin diseases, such as atopic dermatitis, psoriasis, and acne vulgaris. In addition, TLRs have been shown to be important in cutaneous host defense mechanisms against common bacterial, fungal, and viral pathogens in the skin, such as S aureus, C albicans, and HSV. Since the discovery that topical TLR agonists promote antiviral and antitumor immune responses, there has been considerable interest in the development of TLR-based therapies for skin diseases, skin cancer, and infections. Future research involving TLRs in skin will hopefully provide new insights into host defense against skin pathogens and novel therapeutic targets aimed at treating skin disease and skin cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19256306      PMCID: PMC2633625          DOI: 10.1016/j.yadr.2008.09.004

Source DB:  PubMed          Journal:  Adv Dermatol        ISSN: 0882-0880


  88 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients.

Authors:  T J Kang; G T Chae
Journal:  FEMS Immunol Med Microbiol       Date:  2001-07

3.  Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Osamu Takeuchi; Shintaro Sato; Hideki Sanjo; Katsuaki Hoshino; Takao Horiuchi; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

4.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

5.  Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.

Authors:  J Harder; J Bartels; E Christophers; J M Schroder
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

6.  A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection.

Authors:  E Lorenz; J P Mira; K L Cornish; N C Arbour; D A Schwartz
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

7.  Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses.

Authors:  Jenny Kim; Maria-Teresa Ochoa; Stephan R Krutzik; Osamu Takeuchi; Satoshi Uematsu; Annaliza J Legaspi; Hans D Brightbill; Diana Holland; William J Cunliffe; Shizuo Akira; Peter A Sieling; Paul J Godowski; Robert L Modlin
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

8.  Expression of functional Toll-like receptor 2 on human epidermal keratinocytes.

Authors:  Kazuhiro Kawai; Hideki Shimura; Masahiro Minagawa; Akiko Ito; Katsuhiro Tomiyama; Masaaki Ito
Journal:  J Dermatol Sci       Date:  2002-12       Impact factor: 4.563

9.  A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy.

Authors:  Tae Jin Kang; Seong Beom Lee; Gue Tae Chae
Journal:  Cytokine       Date:  2002-10-21       Impact factor: 3.861

10.  Human keratinocytes express functional CD14 and toll-like receptor 4.

Authors:  Peter I Song; Young-Min Park; Tonya Abraham; Brad Harten; Adam Zivony; Natalia Neparidze; Cheryl A Armstrong; John C Ansel
Journal:  J Invest Dermatol       Date:  2002-08       Impact factor: 8.551

View more
  79 in total

Review 1.  Important aspects of Toll-like receptors, ligands and their signaling pathways.

Authors:  Z L Chang
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

2.  The Expression of Toll-like Receptors in Dermatological Diseases and the Therapeutic Effect of Current and Newer Topical Toll-like Receptor Modulators.

Authors:  Whitney Valins; Sadegh Amini; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

3.  Staphylococcus aureus: an introduction.

Authors:  Ian A Myles; Sandip K Datta
Journal:  Semin Immunopathol       Date:  2012-01-27       Impact factor: 9.623

4.  MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.

Authors:  Michael L Davies; Janet J Sei; Nicholas A Siciliano; Ren-Huan Xu; Felicia Roscoe; Luis J Sigal; Laurence C Eisenlohr; Christopher C Norbury
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

5.  The Toll/NF-κB signaling pathway is required for epidermal wound repair in Drosophila.

Authors:  Lara Carvalho; António Jacinto; Nina Matova
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-26       Impact factor: 11.205

6.  Interferon regulatory factor 6 differentially regulates Toll-like receptor 2-dependent chemokine gene expression in epithelial cells.

Authors:  Mei Qi Kwa; Thao Nguyen; Jennifer Huynh; Divya Ramnath; Dominic De Nardo; Pui Yeng Lam; Eric C Reynolds; John A Hamilton; Matthew J Sweet; Glen M Scholz
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

Review 7.  Innate and adaptive immune responses against Staphylococcus aureus skin infections.

Authors:  Sheila Krishna; Lloyd S Miller
Journal:  Semin Immunopathol       Date:  2011-11-06       Impact factor: 9.623

Review 8.  Targeting the skin for microneedle delivery of influenza vaccine.

Authors:  Dimitrios G Koutsonanos; Richard W Compans; Ioanna Skountzou
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

9.  Quiescent innate response to infective filariae by human Langerhans cells suggests a strategy of immune evasion.

Authors:  Alexis Boyd; Sasisekhar Bennuru; Yuanyuan Wang; Vivornpun Sanprasert; Melissa Law; Damien Chaussabel; Thomas B Nutman; Roshanak Tolouei Semnani
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

10.  Toll-like receptors: role in dermatological disease.

Authors:  Aswin Hari; Tracy L Flach; Yan Shi; P Régine Mydlarski
Journal:  Mediators Inflamm       Date:  2010-08-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.